Gara Jalqabaatti › Hemophilia
Qorannoo klinikaalii Hemophilia Ameerikaa Keessatti hirmaatuu
Qorannoo 29 Hemophilia f bakka adda addaa Ameerikaa Keessatti hirmaatuu jiru.
Magaalota qorannoo baay'ee qaban
- Indianapolis, INQorannoo 9
- Los Angeles, CAQorannoo 7
- Seattle, WAQorannoo 6
- Cedar Rapids, IAQorannoo 6
- Philadelphia, PAQorannoo 5
- Little Rock, ARQorannoo 5
- Tampa, FLQorannoo 4
- Sacramento, CAQorannoo 4
- Dallas, TXQorannoo 4
- Atlanta, GAQorannoo 4
- Greenville, NCQorannoo 4
- Orange, CAQorannoo 4
- San Francisco, CAQorannoo 3
- Cincinnati, OHQorannoo 3
- Detroit, MIQorannoo 3
- Kansas City, MOQorannoo 3
- Boston, MAQorannoo 3
- Chicago, ILQorannoo 3
- St. Louis, MOQorannoo 3
- Harrisburg, PAQorannoo 3
- Aurora, COQorannoo 3
- San Antonio, TXQorannoo 3
Naannoon
- ArkansasQorannoo 5
- CaliforniaQorannoo 14
- ColoradoQorannoo 3
- FloridaQorannoo 6
- GeorgiaQorannoo 4
- IllinoisQorannoo 4
- IndianaQorannoo 9
- IowaQorannoo 6
- MassachusettsQorannoo 3
- MichiganQorannoo 5
- MissouriQorannoo 5
- New YorkQorannoo 4
- North CarolinaQorannoo 6
- OhioQorannoo 5
- PennsylvaniaQorannoo 6
- TexasQorannoo 8
- WashingtonQorannoo 6
Qorannoo yeroo dhihootti haaromfaman
Takkalaa qorannoo (Ingiliffa)
A Prospective Assessment of Bone Health in Patients With Severe Hemophilia A on Factor VIII vs Factor Mimetic Prophylaxis (Efa Emi Bone Health Study)
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 30 hanga 50 · Dhiroota · Haaromfame 05-Onk-2026 · NCT07582276Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Dhiroota · Haaromfame 02-Onk-2026 · NCT05568719TG-INSIGHT With Joint POCUS, Hemostatic Potential in Patients With Severe Hemophilia A on Novel Replacement and Substitution FVIII Therapies
Namoota walitti qabaa jiraQorannoo ilaalaa
6 Months · Saalaa hunda · Haaromfame 29-Ful-2026 · NCT07692217A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 1 hanga 17 · Dhiroota · Haaromfame 23-Ful-2026 · NCT05611801Treatment of Hemophilia A Patients With FVIII Inhibitors
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin hundi · Dhiroota · Haaromfame 23-Ful-2026 · NCT04023019A Clinical Study to Evaluate the Effects of NXT007 Compared to Factor VIII Prophylaxis in Participants With Hemophilia A
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 23-Ful-2026 · NCT07416526A Study to Test a Medicine (Fitusiran) for Preventing Bleeds in People With Severe Hemophilia Who Previously Received Preventive Treatment With Emicizumab
Namoota walitti qabaa jiraSadarkaa 4
Umuriin 12 fi ol · Dhiroota · Haaromfame 23-Ful-2026 · NCT06145373A Research Study Looking at How Different Doses of Study Medicine (Inno8) Work in the Body of People With Haemophilia A
Namoota walitti qabaa jiraSadarkaa 1Hojjettoota fayyaa simatamoo
Umuriin 18 hanga 64 · Dhiroota · Haaromfame 18-Ful-2026 · NCT07220564A Gene Therapy Study of SPK-8011QQ in Adults With Severe or Moderately Severe Hemophilia A
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Dhiroota · Haaromfame 11-Ful-2026 · NCT07226206A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of NXT007 in Persons With Severe or Moderate Hemophilia A
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 2 hanga 59 · Dhiroota · Haaromfame 11-Ful-2026 · NCT05987449A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 04-Ful-2026 · NCT07416604Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 0 hanga 20 · Saalaa hunda · Haaromfame 21-Hag-2026 · NCT04278404SAFE Study: Safety of aPCC Following Emicizumab Prophylaxis
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 6 fi ol · Saalaa hunda · Haaromfame 21-Hag-2026 · NCT04563520ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin hundi · Saalaa hunda · Haaromfame 17-Hag-2026 · NCT04398628A Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Than 12 Years With Hemophilia A or B
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 1 hanga 11 · Dhiroota · Haaromfame 17-Hag-2026 · NCT07285460A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SR604 in Two Participants Groups (Part A: Healthy Participants, and Part B: Participants With Hemophilia A or Hemophilia B or Factor VII Deficiency)
Namoota walitti qabaa jiraSadarkaa 1Hojjettoota fayyaa simatamoo
Umuriin 18 hanga 60 · Saalaa hunda · Haaromfame 02-Ado-2026 · NCT06349473Prevention of Bleeding in Patients With Moderate and Severe Hemophilia A Playing Sports: A Comparison Between Factor VIII and Emicizumab Prophylaxis
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 6 hanga 19 · Saalaa hunda · Haaromfame 02-Ado-2026 · NCT05022459Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 1 hanga 74 · Dhiroota · Haaromfame 01-Ado-2026 · NCT05145127A Study to Learn About How Changing Therapy From Emicizumab to Marstacimab Affects People With the Severe Hemophilia A.
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 12 hanga 74 · Dhiroota · Haaromfame 03-Wax-2026 · NCT06703606Efficacy, Safety & Utilisation of Nuwiq, Octanate and Wilate in Previously Untreated & Minimally Treated Haemophilia A Patients
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin hundi · Saalaa hunda · Haaromfame 02-Wax-2026 · NCT03695978Nuwiq for Perioperative Management Of Patients With Haemophilia A on Emicizumab Regular Prophylaxis Study
Namoota walitti qabaa jiraSadarkaa 4
Umuriin 12 fi ol · Dhiroota · Haaromfame 12-Cam-2026 · NCT05935358Nuwiq Dosing and Outcomes In the ManagEment of Women/Girls With Haemophilia A Needing FVIII Treatment for Surgery
Namoota walitti qabaa jiraSadarkaa 4
Umuriin 12 fi ol · Dubartoota · Haaromfame 12-Cam-2026 · NCT05936580ATHNdataset Registry
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin hundi · Saalaa hunda · Haaromfame 21-Elb-2026 · NCT06820515Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 0 hanga 90 · Saalaa hunda · Haaromfame 03-Elb-2026 · NCT05500807Hemophilia A Research Program
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin hundi · Saalaa hunda · Haaromfame 17-Gur-2026 · NCT07414511Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.